Does intervention by an allied health professional discussing adherence to medicines improve this adherence in type 2 diabetes?

Diabetic Medicine

Volumn 27, Issue 12, 2010, Pages 1341-1349

  Doggrell, S A ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Adherance; Medicines; Nurse; Pharmacist; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT;

ALLIED HEALTH EDUCATION; DIABETES EDUCATOR; HEALTH CARE PERSONNEL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE; PATIENT COMPLIANCE; PATIENT COUNSELING; PHARMACIST; REVIEW; SYSTEMATIC REVIEW; TELEPHONE; CLINICAL TRIAL (TOPIC); COST BENEFIT ANALYSIS; PARAMEDICAL PERSONNEL; REMINDER SYSTEM; STATISTICS;

ALLIED HEALTH PERSONNEL; CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; PATIENT COMPLIANCE; REMINDER SYSTEMS;

EID: 79953059226     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03137.x     Document Type: Review

References (34)

1. Bode BW. Defining the importance of daily glycemic control and implications for type 2 diabetes management. Postgrad Med 2009; 121: 82-93.
2. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004; 27: 1218-1224.
3. Donnelly LA, Doney AS, Morris AD, Palmer CN. Long-term adherence to statin treatment in diabetes. Diabet Med 2008; 25: 850-855.
4. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy 2008; 28: 421-436.
5. Carey N, Courtenay M. A review of the activity and effects of nurse-led care in diabetes. J Clin Nurs 2007; 11C: 296-304.
6. Lindenmeyer A, Hearnshaw H, Vermeire E, Van Royen P, Wens J, Biot Y. Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists. J Clin Pharm Ther 2006; 31: 409-419.
7. Rhee MK, Slocum W, Ziemer DC, Culler SD, Cook CB, El-Kebbi IM et al. Patient adherence improves glycemic control. Diabetes Edu 2005; 31: 240-250.
8. Rozenfeld Y, Hunt JS, Plauschinat C, Wong KS. Oral antidiabetic medication adherence and glycemic control in managed care. Am J Manag Care 2008; 14: 71-75.
9. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006; 166: 1836-1841.
10. Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 2003; 25: 2958-2971.
11. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005; 43: 521-530.
12. Centre for Evidence Based Medicine, University of Oxford. Critical appraisal sheets; Systematic Review Critical Appraisal Sheet and RCT Critical Appraisal Sheet http://www.cebn.net/index.aspx?o=1157 (accessed 8 June 2010)
13. Hearnshaw H, Lindenmeyer A. What do we mean by adherence to treatment and advice for living with diabetes? A review of the literature on definitions and measurements Diabet Med 2006; 23: 720-728.
14. Vermiere E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 2001; 26: 331-342.
15. Paes AHP, Bakker A, Soe-Agnie CJ. Measurement of patient compliance. Pharm World Sci 1998; 20: 73-77.
16. Piette JD, Weinberger M, McPhee SJ, Mah CA, Kraemer FB, Crapo LM. Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes? Am J Med 2000; 108: 20-27.
17. Piette JD, Weinberger M, Kraemer FB, McPhee SJ. Impact of automated telephone calls with nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs Health Care System: a randomized controlled trial. Diabetes Care 2001; 24: 202-208.
18. Kim HS, Oh JA. Adherence to diabetes control recommendations: impact of nurse telephone calls. J Adv Nurs 2003; 44: 256-261.
19. Kim HS, Kim NC, Ahn SH. Impact of a nurse short message service intervention for patients with diabetes. J Nurs Care Qual 2006; 21: 266-271.
20. Farmer AJ, Prevost AT, Hardeman W, Craven A, Sutton S, Griffin SJ et al. Protocol for SAMS (Support and Advice for Medication Study): a randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication. BMC Family Practice 2008; 9: 20.
21. Grant RW, Devita NG, Singer DE, Meigs JB. Improving adherence and reducing medication discrepancies in patients with diabetes. Ann Pharmacother 2003; 37: 962-969.
22. Berringer R, Shibley MCH, Cary CC, Pugh CB, Powers AG, Rafi JA. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc 1999; 39: 791-797.
23. Wermeille J, Bennie M, Brown I, McNight J. Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team - a pilot study. Pharm World Sci 2004; 26: 18-25.
24. Odegard PS, Goo A, Hummel J, Williams KL, Gray SL. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother 2005; 39: 433-440.
25. Krass I, Taylor SJ, Smith C, Armour CL. Impact on medication use and adherence of Australian Pharmacists' Diabetes Care Services. J Am Pharm Assoc 2005; 45: 33-40.
26. Armour CL, Taylor SJ, Hourihan F, Smith C, Krass I. Implementation and evaluation of Australian Pharmacists' Diabetes Care Services. J Am Pharm Assoc 2004; 44: 455-466.
27. Planas LG, Crosby KM, Mitchell KD, Farmer KC. Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc 2009; 49: 164-170.
28. Rothman RL, Malone R, Bryant B, Shintani AK, Crigler B, Dewalt DA et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med 2005; 118: 276-284.
29. Phumipamorn S, Pongweharack J, Soorapan S, Pattharachayakul S. Effects of the pharmacist's input on glycaemic control and cardiovascular risks in Muslim diabetes. Primary Care Diabetes 2008; 2: 31-37.
30. Al Mazroui NR, Kamal MM, Ghasbash NM, Yacout TA, Kole PL, McElnay JC. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus. Br J Clin Pharmacol 2009; 67: 547-557.
31. Turnacilar M, Sancar M, Apikoglu-Rabus S, Hursitoglu M, Izzettin FV. Improvement of diabetes indices of care by a short pharmaceutical care program. Pharm World Sci 2009; 31: 689-665.
32. Krier BP, Parker RD, Grayson D, Byrd G. Effect of diabetes education on glucose control. J La State Med Soc 1999; 151: 86-92.
33. Jiang YD, Chuang lM, Wu HP, Shiau SJ, Wang CH, Lee YJ et al. Assessment of the function and effects of diabetes education programs in Taiwan. Diabetes Res Clin Pract 1999; 46: 177-182.
34. Rosen MI, Rigsby MO, Salahi JT, Ryan CE, Cramer JA. Electronic monitoring and counseling to improve medication adherence. Behav Res Ther 2004; 42: 409-422.